Larry Altstiel

Larry Douglas Altstiel was the founder of Provectra Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer from 2013 to 2015.
Current jobs include Chief Medical Officer at Pinteon Therapeutics, Inc. and Chief Medical Officer at ProMIS Neurosciences, Inc. since 2022.
Former jobs include Director at Neurotrope, Inc. from 2014 to 2016; Vice President-Neuroscience Clinical Development at Pfizer Inc. in 2013; Vice President-Research Operations at Eisai Medical Research, Inc.; Senior VP & Head-Global Clinical Development at UCB Biosciences, Inc.; Vice President-Research Operations at Schering Plough, Inc.; and Chief Medical Officer & Executive Vice President at vTv Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate studies at the University of Illinois, a doctorate from The Rockefeller University, and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.